ES/iPSs Cells, Media&Tools 2024

Adult Stem Cells, ES/IPS & Diseased Cells offered by PELOBiotech. We offer a lot in the field of Stem Cells, but what else does PELOBiotech offer? We are more than competent4cells – and that also in the field of Stem Cells. From quality products to fast delivery we are your competent cell culture experts. We are the qualified, solution-oriented experts you have been looking for. We provide you with one of the best cell portfolios for your research needs. We fill the gap and build a bridge between innovative research and the special requests of the clinical sector. Get proficient recommendations and info first hand.

www.pelobiotech.com

www.pelobiotech.com PB-cAP- 0500- 001GFP PB-cAP- 0500- 001RFP PB-cAP- GFP Expressing Human Induced Pluripotent Stem Cells 1 Vial Angio- Proteomie RFP-Expressing Human Induced Pluripotent Stem Cells 1 Vial Angio- Proteomie Human Induced Pluripotent Stem Cells 1 Vial Angio- 0500-002 Proteomie 30HU-002 Human iPSC Line (Normal) 0.5-1.0 million cells/vial IXCells 30HU-003 Human iPSC Line (Parkinson's Disease Patient, Sporadic) 0.5-1.0 million cells/vial 30HU-004 Human iPSC Line (Amyotrophic Lateral Sclerosis Patient, Sporadic) 0.5-1.0 million cells/vial 30HU-005 Human iPSC Line (Type 2 Diabetes) 0.5-1.0 million cells/vial 30HU-008 Human iPSC Line (Alzheimer's Disease Patient, PSEN2, N141I, HET) 0.5-1.0 million cells/vial 30HU-009 Human iPSC Line (Alzheimer's Disease Patient, Sporadic) ~0.5-1.0 million cells/vial 30HU-101 Human iPS Cell Line (SOD1 mutation, A4V, HOM) Available on request IXCells IXCells IXCells IXCells IXCells IXCells 7.2 iPS-Derived Cells iPSCs hold significant promise for personalized regenerative therapies since the derivation of these cells into another form while maintaining the genetic composition from an individual's own tissue essentially bypasses immunological barriers. Applications of iPSCs currently span various fields, including neurology, liver disease analysis, cancer therapy, and regenerative medicine and their uses are only just beginning. 16

www.pelobiotech.com For therapeutic applications, during the reprogramming process researchers must first improve the safety while reducing tumorigenicity aspects. The continual research in these areas underscores the dynamic nature of iPSCs and their potential impact on advancing both basic understanding and clinical applications. We carry a wide range of iPSC-derived cells from our many partners including but not limited to Tempo Bioscience, iXCells Biotechnologies, REPROCELL®, Angio-Proteomie, and Cell Applications. Cat # Product Quantity Supplier PB-cAP-0500-002- 01 Human Induced Pluripotent Stem Cells- Derived Neural Precursor Cells (iPSC-NPCs) 1 Vial Angio- Proteomie PB-cAP-0500-002- 02 Human Induced Pluripotent Stem Cells- Derived Endothelial Cells 1 Vial Angio- Proteomie PB-cAP-0500-002- 03 Human Induced Pluripotent Stem Cells- Derived Astrocytes 1 Vial Angio- Proteomie PB-cAP-0500-002- 04 Human Induced Pluripotent Stem Cells- Derived Neuron Cells 1 Vial Angio- Proteomie PB-i536-05 Cryopreserved AEC2/i-HAEpC2 0,5x10E6 cells/vial Cell Applications PB-i820-10 Cryopreserved iPSC-derived Neural Stem Cells (i-HNSC) 1x10E6 cells/vial Cell Applications PB-i357-20 Cryopreserved iPSC-Derived Cardiac Cells 2x10E6 cells/vial Cell Applications 40HU-001 Human Neural Stem Cells (iPSC-derived, 2x10E6 cells/vial IXCells Normal) 40HU-002- CHCHD2-R145Q- HOM-1M Human Dopaminergic Neurons (iPSCderived, CHCHD2, R145Q, HOM) 1x10E6 cells/vial IXCells 40HU-002- CHCHD2-R145Q- HOM-2M 40HU-002- CHCHD2-R145Q- ISO-1M 40HU-002- CHCHD2-R145Q- ISO-2M 40HU-005-1M 40HU-005-2M 40HU-005-4M 40HU-006-1M 40HU-006-2M 40HU-006-4M Human Dopaminergic Neurons (iPSCderived, CHCHD2, R145Q, HOM) Human Dopaminergic Neurons (iPSCderived, CHCHD2, R145Q, ISO) Human Dopaminergic Neurons (iPSCderived, CHCHD2, R145Q, ISO) Human Motor Neurons (iPSC-derived, Normal) Human Motor Neurons (iPSC-derived, Normal) Human Motor Neurons (iPSC-derived, Normal) Human Motor Neurons (iPSC-derived, Amyotrophic Lateral Sclerosis Patient, Sporadic) Human Motor Neurons (iPSC-derived, Amyotrophic Lateral Sclerosis Patient, Sporadic) Human Motor Neurons (iPSC-derived, Amyotrophic Lateral Sclerosis Patient, Sporadic) 2x10E6 cells/vial 1x10E6 cells/vial 2x10E6 cells/vial 1x10E6 cells/vial 2x10E6 cells/vial 4x10E6 cells/vial 1.0 million cells/vial 2x10E6 cells/vial 4.0 million cells/vial IXCells IXCells IXCells IXCells IXCells IXCells IXCells IXCells IXCells 17